Vicuron Holdings Drug Patent Portfolio
Vicuron Holdings owns 1 orange book drug protected by 3 US patents Given below is the list of Vicuron Holdings's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6960564 | Echinocandin pharmaceutical formulations containing micelle-forming surfactants | 12 Apr, 2021 | Expired |
| US7709444 | Echinocandin pharmaceutical formulations containing micelle-forming surfactants | 12 Apr, 2021 | Expired |
| US5965525 | Cyclic peptide antifungal agents | 17 Feb, 2020 | Expired |
Latest Legal Activities on Vicuron Holdings's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Vicuron Holdings.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 06 Jun, 2022 | US7709444 |
|
Maintenance Fee Reminder Mailed
Critical
| 20 Dec, 2021 | US7709444 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 16 Oct, 2017 | US7709444 |
|
Correspondence Address Change
Critical
| 23 Aug, 2010 | US7709444 |
| Post Issue Communication - Certificate of Correction | 10 Aug, 2010 | US7709444 |
|
Email Notification
Critical
| 27 Jul, 2010 | US7709444 |
| Mail-Record a Petition Decision of Granted to Issue Patent in Name of the Assignee | 20 Jul, 2010 | US7709444 |
| Record a Petition Decision of Granted to Issue Patent in Name of the Assignee | 19 Jul, 2010 | US7709444 |
| Petition Entered | 14 Jun, 2010 | US7709444 |
| Post Issue Communication - Certificate of Correction Denied | 16 May, 2010 | US7709444 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 04 May, 2010 | US7709444 |
|
Recordation of Patent Grant Mailed
Critical
| 04 May, 2010 | US7709444 |
|
Email Notification
Critical
| 15 Apr, 2010 | US7709444 |
|
Issue Notification Mailed
Critical
| 14 Apr, 2010 | US7709444 |
| Dispatch to FDC | 24 Mar, 2010 | US7709444 |
Vicuron Holdings's Family Patents
Vicuron Holdings Drug List
Given below is the complete list of Vicuron Holdings's drugs and the patents protecting them.
1. Eraxis
Eraxis is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6960564 | Echinocandin pharmaceutical formulations containing micelle-forming surfactants |
12 Apr, 2021
(3 years ago)
| Expired |
| US7709444 | Echinocandin pharmaceutical formulations containing micelle-forming surfactants |
12 Apr, 2021
(3 years ago)
| Expired |
| US5965525 | Cyclic peptide antifungal agents |
17 Feb, 2020
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Eraxis's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List